MOBILE, Ala., July 8, 2011 /PRNewswire/ -- HASCO Medical, Inc. (OTCBB: HASC), www.mysouthernmed.com, a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, announced that it has reached an agreement with G.E. Capital to serve as its floor plan financier for both Braun (www.braunability.com) and VMI (www.vantagemobility.com) vehicles at all of its dealerships. This agreement positions Mobility Freedom to stock several new makes and models at each location so customers can pick the vehicle that fits their specific needs immediately.
Under the terms of the agreement, the Company has a $2.3 million dollar credit line with G.E. Capital to floor plan vehicles. The first 60 days is interest free financing on each vehicle.
“We are very pleased to have G.E. Capital’s support, as we continue to grow and expand Mobility Freedom. We are also excited about the ability to stock more inventory for our customers, both are huge wins for Mobility Freedom,” stated Hal Compton, CEO of HASCO Medical.
About HASCO Medical, Inc.
HASCO Medical (“HASC” or the Company) provides products and services that dramatically improve the quality of living for its customers. The Company’s products and services include the sale of durable medical equipment, home respiratory equipment and the sale or rental of wheelchair accessible vans for which it provides custom conversion services. The Company operates in the South Eastern portion of the United States including Alabama, Mississippi and Florida. The Company’s objective is to be a leading provider of home health care products and services in the continental United States. For more information on Mobility Freedom, please visit www.mobilityfreedom.com.
This press release may contain forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases you can identify those so-called “forward looking statements” by words such as “may,” “will,” “should,” “expects,” “plans,” “targets,” “believes,” “anticipates,” “estimates,” “predicts,” “potential,” or “continue” or the negative of those words and other comparable words. These forward looking statements are subject to risks and uncertainties, product tests, commercialization risks, availability of financing and results of financing efforts that could cause actual results to differ materially from historical results or those anticipated. Further information regarding these and other risks is described from time to time in the Company’s filings with the SEC, which are available on its website at: http://www.sec.gov. We assume no obligation to update or alter our forward-looking statements made in this release or in any periodic report filed by us under the Securities Exchange Act of 1934 or any other document, whether as a result of new information, future events or otherwise, except as otherwise required by applicable federal securities laws.
SOURCE HASCO Medical, Inc.
